Company Profiles

driven by the PitchBook Platform

Asceneuron

Description

Provider of therapeutics treatment for Alzheimer's disease. The company develops therapeutics for orphan tauopathies and improved symptomatic drugs for Alzheimer's disease.

2012

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$37.1M

Total Amount Raised

8

Investors

Description

Provider of therapeutics treatment for Alzheimer's disease. The company develops therapeutics for orphan tauopathies and improved symptomatic drugs for Alzheimer's disease.

Website:

www.asceneuron.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Healthcare Services

Primary Office

EPFL Innovation Park Bâtiment B 1015 LausanneSwitzerland
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Asceneuron's full profile, request a free trial.

    Asceneuron Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Asceneuron Investors (8)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Alzheimers Drug Discovery FoundationOther000 0000000 0000
    EPFL Innovation ParkAccelerator/Incubator000 0000000 0000
    Johnson & Johnson Innovation - JJDCCorporate Venture CapitalMinority000 0000000 0000
    Kurma PartnersVenture CapitalMinority000 0000000 0000
    Merck VenturesCorporate Venture CapitalMinority000 0000000 0000
    Alzheimers Drug Discovery Foundation Other
    EPFL Innovation Park Accelerator/Incubator
    Johnson & Johnson Innovation - JJDC Corporate Venture Capital
    Kurma Partners Venture Capital
    Merck Ventures Corporate Venture Capital

    Asceneuron Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Dirk Beher Ph.DChief Executive Officer, Board Member and Co-Founder
    Christoph Wiessner Ph.DChief Operating Officer & Vice President, Research & Development, Co-Founder
    Anna Quattropani Ph.DHead, Medicinal Chemistry
    Bruno PermanneHead, vitro pharmacology
    Michael RyanChief Medical Officer
    Dirk Beher Ph.D Chief Executive Officer, Board Member and Co-Founder
    Christoph Wiessner Ph.D Chief Operating Officer & Vice President, Research & Development, Co-Founder
    Anna Quattropani Ph.D Head, Medicinal Chemistry
    Bruno Permanne Head, vitro pharmacology
    Michael Ryan Chief Medical Officer

    Asceneuron Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Deborah Harland Ph.DSR OnePartner000 0000
    Dirk Beher Ph.DAsceneuronChief Executive Officer, Board Member and Co-Founder000 0000
    Franz Hefti Ph.DSelfBoard Member000 0000
    Hakan Goker Ph.DMerck VenturesSenior Investment Director000 0000
    Hans Schikan Ph.DSelfChairman000 0000
    Deborah Harland Ph.D Partner SR One
    Dirk Beher Ph.D Chief Executive Officer, Board Member and Co-Founder Asceneuron
    Franz Hefti Ph.D Board Member Self
    Hakan Goker Ph.D Senior Investment Director Merck Ventures
    Hans Schikan Ph.D Chairman Self
    Request full access to PitchBook